1. Home
  2. ARCB vs SUPN Comparison

ARCB vs SUPN Comparison

Compare ARCB & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARCB

ArcBest Corporation

HOLD

Current Price

$141.12

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$43.53

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCB
SUPN
Founded
1923
2005
Country
United States
United States
Employees
14000
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
ARCB
SUPN
Price
$141.12
$43.53
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$122.75
$61.60
AVG Volume (30 Days)
232.3K
581.4K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,657,864,000.00
$392,755,000.00
Revenue This Year
$7.00
$22.70
Revenue Next Year
$5.80
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
12.56
N/A
52 Week Low
$59.43
$42.45
52 Week High
$176.69
$59.68

Technical Indicators

Market Signals
Indicator
ARCB
SUPN
Relative Strength Index (RSI) 46.00 41.02
Support Level $134.67 $44.09
Resistance Level $148.59 $52.33
Average True Range (ATR) 5.68 1.30
MACD -0.06 -0.29
Stochastic Oscillator 35.69 19.63

Price Performance

Historical Comparison
ARCB
SUPN

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: